PATENT

Patent Granted

• Alpha Glucosidase Inhibitory Activity of Novel Ruthenium(II)-Polypyridine Complexes Containing 4-Amino-5-(4-pyridyl)-4H-1,2,4-triazole-3-thiol Ligands. Patent No. 431538, Granted on 11/05/ 2023, Application No. 202141037162, Date of filing: 27/12/2021.

• Fibre hair pro helmet (Design Patent), Design No. 395052-001, Granted on 16/10/2025, filed on 14/09/2023.

Patent Published

1. 1. In vitro antiproliferative, cytotoxic and apoptotic effect of Ruthenium(II)-polypyridine-3-benzoyl picolinic acid complexes on SK-MEL-28 and normal L6 cell lines". Application No. 202141037162, Published in The Patent Office Journal No. 35/2021 Dated 27/08/2021, Page No. 38174.

   2. A novel helmet attachment system: enhancing comfort, safety, and hair protection with vetiver root cooling and climate shielding. Application No. 202341061764, published in The Patent Office Journal No. 40/2023 Dated 06/10/2023, Page No. 67002.

   3. A novel ruthenium(II)-bis(benzimidazol-2-yl)pyridine-Chlorophenylterpyridine complex: in vitro anticancer and cytotoxic potentials on breast Cancerous MDA-MB-231 and normal L6 cell lines. Application No. 202441026883, published in The Patent Office Journal No. 15/2024 Dated 12/04/2024, Page No. 35542.

   4. A novel ruthenium(II)Chlorophenylterpyridine-chloroterpyridine complex: In vitro anticancer and cytotoxic potentials on breast cancerous MDA-MB-231, colon cancerous HCT-116 and normal L6 cell lines. Application No. 202441040845, published in The Patent Office Journal No. 22/2024 Dated 31/05/2024, Page No. 50191.

   5. Novel ruthenium(II)-biquinoline-4,4′ dicarboxylic acid complex catalyst for direct β-alkylation of alcohols. Application No. 202541035869, published in The Patent Office Journal No. 19/2025 Dated 09/05/2025 Page No. 43860.

   6. Ruthenium(II) terpyridine-biquinoline dicarboxylic acid complex with potent anticancer activity. Application No. 202541035868, published in The Patent Office Journal No. 19/2025 Dated 09/05/2025 Page No. 43859. Application No. 202541035868.

   7. Anticancer and cytotoxic potentials of novel ruthenium(II)benzimidazol-2-yl)pyridine-chloroterpyridine complex on MDA-MB-231, HCT-116 and normal L6 cell lines. Application No. 202541035828, published in The Patent Office Journal No. 19/2025 Dated 09/05/2025 Page No. 43845.